11C-DASB

DRUG2 trials

Sponsors

Institut National De La Sante Et De La Recherche Medicale, National Institutes of Health Clinical Center (CC)

Conditions

DepressionHIV InfectionsHIV-Associated Cognitive Motor ComplexParkinson's diseaseProdromal phase of Parkinson's disease

Phase 1

PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects

CompletedNCT03581305

National Institutes of Health Clinical Center (CC)Depression, HIV-Associated Cognitive Motor Complex, HIV Infections

Start: 2018-11-20End: 2022-04-06Updated: 2023-03-21

Phase 2

Assessment of the impairment of the serotoninergic system during the prodromal phase of Parkinson’s disease in SNCA mutation carriers by PET using [11C]DASB and [11C]SB207145 : SerIAL-PD

Not yet recruitingCTIS2024-516610-38-00

Institut National De La Sante Et De La Recherche MedicaleParkinson's disease, Prodromal phase of Parkinson's disease

Target: 50Updated: 2025-08-29